RBC Capital Maintains Outperform on HealthEquity, Raises Price Target to $77
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Sean Dodge maintains an 'Outperform' rating on HealthEquity (NASDAQ:HQY) and raises the price target from $75 to $77.
September 06, 2023 | 2:05 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
RBC Capital maintains an 'Outperform' rating on HealthEquity and raises the price target from $75 to $77.
The news is directly related to HealthEquity (HQY). The 'Outperform' rating maintained by RBC Capital and the increase in price target from $75 to $77 indicates a positive outlook for the company. This could potentially lead to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100